KMDA Latest Press Releases

-- August 17, 2026 --

Kamada Declares Cash Dividend of $0.17 Per Share; The Company Reported Record-High Revenue and Profitability for First Six Months of 2026 Globe Newswire 7:00 AM

-- August 12, 2026 --

Kamada Reports Record-High First Half and Second Quarter 2026 Financial Results, Representing Double-Digit Profitable Growth and the Strongest in Kamada's History; Affirms 2026 Annual Guidance Globe Newswire 7:05 AM

Kamada Announces Planned Transition of Chief Financial Officer Globe Newswire 7:00 AM

-- August 5, 2026 --

Kamada to Announce Second Quarter and First Half Ended June 30, 2026 Financial Results on August 12, 2026 Globe Newswire 7:00 AM

-- July 20, 2026 --

Kamada Announces a Three-Year $50 Million Sales Agreement to Supply Plasma to a Leading Biopharmaceutical Company focused on Plasma-derived Therapies Globe Newswire 7:00 AM

-- July 13, 2026 --

Kamada Highlights CYTOGAM Study Results Presented at the 2026 ISHLT Annual Meeting Globe Newswire 7:00 AM

-- June 1, 2026 --

Kamada Announces FDA Approval of its New In-House Rabies Virus Neutralization Testing Laboratory Globe Newswire 7:00 AM

-- May 13, 2026 --

Kamada Reports First Quarter 2026 Financial Results and Affirms 2026 Annual Guidance; Expecting Significantly Stronger Remainder of the Year Globe Newswire 7:00 AM

-- May 6, 2026 --

Kamada to Announce First Quarter 2026 Financial Results on May 13, 2026 Globe Newswire 7:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software